Seasonal & H1N1 Vaccine Information

Seasonal Flu Vaccine Information

Niagara University’s seasonal flu shot clinic has been rescheduled for Monday, Nov. 16, from 3-6 p.m. in  St. Vincent’s Hall, Rooms 405-406. Vaccines will be administered on a first-come, first-served basis. Please bring your insurance card.

H1N1 Vaccine Update — 11/16/09

The Office of Health Services has received a supply of the H1N1 nasal flu mist and will administer it on a first-come, first-served basis to healthy students between the ages of 2-49 who are not pregnant and do not have the health conditions identified below.

The following H1N1 Flu clinics will be available

• Nov. 17 from 1-4 p.m. Lower Level Gallagher Center
• Nov. 18 from 11 a.m.-2 p.m. Health Services, Butler Building #15

The H1N1 nasal flu mist is a live, attenuated intranasal vaccine (LAIV), which means it is weakened so it will not cause illness. LAIV is sprayed into the nose and does not contain thimerosal, mercury, or other preservatives. It is licensed for administration to healthy people from 2 through 49 years of age.

The following individuals cannot get the LAIV: (You must get the injectable vaccine when available)

• Pregnant women
• Individuals who are ill, or have had a fever in the past 24 hours
• Individuals who have received the seasonal flu mist, chicken pox vaccine, a MMR vaccination in the past 28 days
• If you have been treated with (within the past 14 days)  or are currently taking an anti-viral medication
• Allergies to eggs or other substances in the vaccine
• Individuals who have an severe allergy to latex
• Individuals who have had a life-threatening allergic reaction after a dose of seasonal flu vaccine
• Individuals with long-term health problems such as heart disease, lung disease, asthma, kidney or liver disease, metabolic diseases such as diabetes, anemia and other blood disorders
• Individuals who have had Guillain-Barre syndrome
• Anyone on long term aspirin therapy
• Individuals with certain muscle or nerve disorders (such as cerebral palsy) that can lead to breathing or swallowing problem
• Anyone with a weakened immune system or in close contact with a person with a severely weakened immune system (bone marrow transplant, leukemia, cancer, AIDS, transplant patients)

Please continue to monitor this site for further information on the availability of the H1N1 vaccine (injectable).  The arrival of future doses is unknown; however the Centers for Disease Control and the NYS Department of Health expect a large distribution of the H1N1 vaccine (injectable) near the end of November or early December.